Researchers and scientists at the Russian Jamalia Center for Microbiology are working on a unified vaccine against both influenza and the Corona virus, and the new vaccine is scheduled to be launched in 2022, according to the Russian newspaper, Izvestia.
Professor Alexander Ginsburg, head of the Russian Jamalia Center for Microbiology, confirmed that the new vaccine will be based on a hybrid vaccine against rotaviruses, noting that the center’s scientists are working at the same time to prepare vaccines against different strains of the coronavirus, and Ginsburg said that clinical tests The new vaccine has not yet been launched, but a technology platform for the vaccine exists.
And he continued, “If all goes well with the technological platform for the vaccine and its effectiveness is confirmed, we will move to a more complex option, which is to combine the vaccine against influenza and the Corona virus together” in one vaccine, and we expect its clinical tests to be launched at the end of next year..
Professor at the Jamalia Center, Alexander Butenko, said that the center’s scientists have begun to develop compound vaccines that will contain antigens for many of the dominant genotypes of the Corona virus that will protect against all strains of the coronavirus..
The new vaccine that scientists are testing consists of the proteins of many strains of the Corona virus, and contains 3, 4 or 5 different genetic variations of the protein. S in one vaccine.
The first phase of clinical trials of the vaccine could begin early next year, and clinical trials will not begin until after the success of the initial trials of the vaccine.